Anna T. Levy, DO, discuses the safety profile and appropriate dosing of cabozantinib in patients with hepatocellular carcinoma.
Anna T. Levy, DO
Advertisement
Articles by Anna T. Levy, DO
Anna T. Levy, DO, discuses future research directions for lenvatinib in patients with hepatocellular carcinoma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
JNJ-87189401 Plus Pasritamig Drives Deep PSA Responses With Favorable Safety in Pretreated mCRPC
2
Cesalatamig Monotherapy Shows Dose-Dependent Activity in PD-(L)1 Inhibitor–Experienced NSCLC
3
Dr Moser on Outcomes for WTX-124 ± Pembrolizumab in Advanced Immune-Sensitive Solid Tumors
4
Dr Banks on the Feasibility of Lifileucel in Select Metastatic Sarcomas
5